Clinical trial
Utilising Volumetric Absorptive Microsampling (VAMS®) Technology to Monitor Tacrolimus and Creatinine Concentrations in Adult Renal Transplant Patients
NCT06445205 is registered in ClinicalTrials.gov with Lancashire Teaching Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utilising Volumetric Absorptive Microsampling (VAMS®) Technology to Monitor Tacrolimus and Creatinine Concentrations in Adult Renal Transplant Patients
- Lead sponsor
- Lancashire Teaching Hospitals NHS Foundation Trust
- Phase
- Observational
- Overall status
- Suspended
- Start date
- February 13, 2024
- Completion date
- November 30, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney replacement, kidney transplant rejection